These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 307642)

  • 1. Turning in MFB-lesioned rats and antagonism of neuroleptic-induced catalepsy after lisuride and LSD.
    Pieri M; Schaffner R; Pieri L; Da Prada M; Haefely W
    Life Sci; 1978 May; 22(18):1615-22. PubMed ID: 307642
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain.
    Kehr W; Speckenbach W
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):163-9. PubMed ID: 305542
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.
    White FJ; Appel JB
    Science; 1982 Apr; 216(4545):535-7. PubMed ID: 7071600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of drug-induced rotation in rats lesioned in the medial forebrain bundle with 5,6-dihydroxytryptamine or 6-hydroxydopamine.
    Pieri M; Pieri L; Saner A; Da Prada M; Haefely W
    Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):118-30. PubMed ID: 127559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Neuropharmacology; 1983 Jun; 22(6):669-76. PubMed ID: 6888664
    [No Abstract]   [Full Text] [Related]  

  • 6. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonism of a behavioral effect of LSD and lisuride in the cat.
    White FJ; Holohean AM; Appel JB
    Psychopharmacology (Berl); 1983; 80(1):83-4. PubMed ID: 6408677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lisuride and LSD on cerebral monoamine systems and hallucinosis.
    Pieri L; Keller HH; Burkard W; Da Prada M
    Nature; 1978 Mar; 272(5650):278-80. PubMed ID: 203869
    [No Abstract]   [Full Text] [Related]  

  • 9. Discriminative stimulus properties of clonidine: substitution by ergot derivatives.
    Cunningham KA; Callahan PM; Craigmyle NA; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(3):225-9. PubMed ID: 2868902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy.
    Morelli M; Porceddu ML; Imperato A; Di Chiara G
    Brain Res; 1981 Aug; 217(2):375-9. PubMed ID: 6972799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine agonists increase pallidal unit activity: attenuation by agonist pretreatment and anesthesia.
    Bergstrom DA; Bromley SD; Walters JR
    Eur J Pharmacol; 1984 Apr; 100(1):3-12. PubMed ID: 6723776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and behavioral effects of serotonin neurotoxins on the nigrostriatal dopamine system: comparison of injection sites.
    Giambalvo CT; Snodgrass SR
    Brain Res; 1978 Sep; 152(3):555-66. PubMed ID: 308384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide.
    Adams LM; Geyer MA
    Pharmacol Biochem Behav; 1985 Sep; 23(3):461-8. PubMed ID: 4048241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.
    Chiu S; Mishra RK
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):45-50. PubMed ID: 6111027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.
    Leccese AP; Lyness WH
    Brain Res; 1984 Jun; 303(1):153-62. PubMed ID: 6610461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic and dopaminergic effects of yawning in the cat.
    Marini JL
    Pharmacol Biochem Behav; 1981 Nov; 15(5):711-5. PubMed ID: 7312907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisuride.
    Wachtel H; Dorow R
    Life Sci; 1983 Jan; 32(4):421-32. PubMed ID: 6827903
    [No Abstract]   [Full Text] [Related]  

  • 19. Rotational responses to serotonergic and dopaminergic agonists after unilateral dihydroxytryptamine lesions of the medial forebrain bundle: co-operative interactions of serotonin and dopamine in neostriatum.
    Waddington JL; Crow TJ
    Life Sci; 1979 Oct; 25(15):1307-14. PubMed ID: 316093
    [No Abstract]   [Full Text] [Related]  

  • 20. Lisuride- and D-LSD-induced changes of monoamine turnover in the rat brain.
    Keller HH; Burkard WP; Pieri L; Bonetti EP; Da Prada M
    Adv Biochem Psychopharmacol; 1978; 19():393-6. PubMed ID: 696467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.